SCHEMBL28656322

SCHEMBL28656322

CCOC(=O)C=Cc1csc(N=[N+]=[N-])n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
TTR P02766 1/20 0.36
DPP4 P27487 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
CYP3A4 P08684 1/20 0.35
KDM4E B2RXH2 1/20 0.35
FDPS P14324 1/20 0.35
P2RY12 Q9H244 1/20 0.35
MAOB P27338 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412422 0.78 HDAC1 (0.47) CA12CA1CA2CA7CA9
SCHEMBL9331716 0.78 HDAC1 (0.47) CA12CA1CA2CA7CA9
SCHEMBL16382705 0.77 HDAC3 (0.56) CA12CA1CA2CA7CA9
SCHEMBL28607205 0.77 HDAC3 (0.56) CA12CA1CA2CA7CA9
SCHEMBL26246354 0.76 MAPT (0.52) CA12CA1CA2CA7CA9
SCHEMBL28541644 0.75 CA12 (0.39) CA12CA1CA2CA7CA9
SCHEMBL8852985 0.74 TTR (0.43) CA12CA1CA2CA7CA9
SCHEMBL8852995 0.74 TTR (0.43) CA12CA1CA2CA7CA9
SCHEMBL28344842 0.71 CA12 (0.43) CA12CA1CA2CA7CA9
SCHEMBL28833725 0.68 DPP4 (0.40) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107787322-B Tricyclic compounds and their use as phosphodiesterase inhibitors 辉瑞大药厂 2023-07-07 CN disclosed
CN-113646050-A Thieno [3,2-B ] pyrrolo [3,2-D ] pyridazinone derivatives and their use as PKM2 derivatives for the treatment of cancer, obesity and diabetes related disorders 安吉奥斯医药品有限公司 2021-11-12 CN disclosed